Siemens Healthineers AG (SEMHF) Stock Analysis & Winston Score
Siemens Healthineers makes medical equipment and software used in hospitals and clinics around the world. Its core products include MRI machines, CT scanners, X-ray systems, and laboratory diagnostic tools. The company also provides cancer treatment technology through its Varian division, which it acquired in 2021, making Siemens Healthineers one of the largest medical technology companies in the world. The company earns money by selling imaging equipment, diagnostic instruments, and related software, as well as through service contracts and consumables that generate recurring revenue. It operates globally, with strong presence in Europe, North America, and Asia, and reported roughly $23 billion in annual revenue in its most recent fiscal year. Its large installed base of equipment creates switching costs, since hospitals tend to stick with familiar systems and service providers. The key growth driver is expanding demand for advanced diagnostics and cancer care, while currency fluctuations and pricing pressure in competitive imaging markets remain ongoing risks.
Winston Score: 55/100 — Good
A decent business — some strong pillars, some weaker.
- Quality: Mixed (13/30)
- Growth: Mixed (7/20)
- Cash Flow: Strong (8/10)
- Stability: Good (6/10)
- Valuation: Strong (7/10)
- Ownership: Good (10/15)
Key Facts
Price: $46.66
Market Cap: $52.2B
Sector: Healthcare
Industry: Medical - Devices
Exchange: Other OTC


